TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.86 CNY | -1.18% |
|
+5.43% | +9.54% |
| 30/04 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
| 30/04 | Tianjin Pharmaceutical's Q1 Attributable Profit Slips 3% | MT |
Evolution of the average Target Price on Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Price target over the last 5 years
History of analyst recommendation changes
c2c1c9836f51f0c28b312653a04fbf.vaoXGGFZ6q4xzH25uk9ejw8D6kHoFvQGNqv08mTQePo.8NpzdidusN92vxfw-Ahz_kBui3eRL8V1XOmxn1P9Ms3u7nl0DR6B4GmIGg~abd2cecc41849ddef90b7d9a7309f3e5
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
36.86
CNY
Average target price
45.8
CNY
Spread / Average Target
+24.25%
High Price Target
45.8
CNY
Spread / Highest target
+24.25%
Low Price Target
45.8
CNY
Spread / Lowest Target
+24.25%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
- Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited